US Stock MarketDetailed Quotes

DHR Danaher

Watchlist

234.840
+5.030+2.19%

Close Jan 3 16:00 ET

234.840
0.0000.00%

Post 17:20 ET

169.62BMarket Cap44.82P/E (TTM)

Danaher Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Danaher Q3 2024 Earnings Date

Currency：USDOct 22, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	5.59B	5.80B	+210.47M
Beat Est.	-18.70%	+3.09%	+3.77%
EPS	1.12	1.12	-<0.01
Miss Est.	-25.70%	-25.83%	-0.18%

Analyst Rating

Strong Buy

Jan 3, 2025

Danaher Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 6.020B	--
Jan 29, 2025	2024/Q4	-- / 6.388B	--
Oct 22, 2024	2024/Q3	5.798B / 5.588B	--
Jul 23, 2024	2024/Q2	5.743B / 5.585B	--
Apr 23, 2024	2024/Q1	5.796B / 5.619B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 6.020B--

Jan 29, 20252024/Q4-- / 6.388B--

Oct 22, 20242024/Q35.798B / 5.588B--

Jul 23, 20242024/Q25.743B / 5.585B--

Apr 23, 20242024/Q15.796B / 5.619B--

Unlock Free Earnings Estimates

Open Account

Danaher Earnings Reports

Danaher | 8-K: Danaher Reports Third Quarter 2024 Results

Oct 22, 2024 16:01 ET

Danaher | 10-Q: Q3 2024 Earnings Report

Oct 22, 2024 16:01 ET

Danaher | 8-K: Danaher Reports Second Quarter 2024 Results

Jul 23, 2024 16:22 ET

Danaher | 10-Q: Q2 2024 Earnings Report

Jul 23, 2024 16:22 ET

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Jan 3, 2025

Strong Buy

Buy
75.00%
Hold
25.00%
Sell
0.00%

Price Target

No Data